I wrote about Illumina (ILMN) yesterday and mentioned the one downside was some patent issues; the stock has gapped up this morning upon a re-examnination on these patents.
“We are pleased to hear that the U.S. Patent Office has decided to re-examine the validity of these two patents. We expect the Patent Office to consider closely the applicability of the prior art in their evaluation of whether these patents should be amended or invalidated in their entirety,” said Jay Flatley, President and Chief Executive Officer of Illumina.
Long Illumina in fund; no personal position
